Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2019 · 10-Q
Revenue—
Net Income-$9.15M-$9.15MN/M vs Q2 2018 EPS Diluted-$20.67-$20.67N/M vs Q2 2018 Operating Income-$1,959,000N/M Operating Cash Flowderived-$1,150,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,150,000N/M ended Jun 30, 2019 · filed Aug 15, 2019 · 46 d after period end